The effectiveness of Check of Medication Appropriateness for antimicrobial stewardship: an interrupted time series

Charlotte Quintens1,2, Willy E Peetermans3,4, Katrien Lagrou3,5

  • 1Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.

Abstract

Insights

The Check of Medication Appropriateness (CMA) significantly reduced inappropriate antimicrobial prescriptions in hospitals. This pharmacist-led review service lowered residual potentially inappropriate prescriptions (PIPs) by 86.7%, improving antimicrobial stewardship.

Area of Science:

  • Hospital Pharmacy
  • Antimicrobial Stewardship
  • Clinical Pharmacy Practice

Background:

  • Inappropriate antimicrobial prescribing fuels antimicrobial resistance and adverse drug events.
  • Antimicrobial Stewardship (AMS) programs aim to optimize antimicrobial use.
  • Pharmacist-led medication reviews are crucial for identifying and rectifying prescribing errors.

Purpose of the Study:

  • To evaluate the impact of the 'Check of Medication Appropriateness' (CMA) on antimicrobial prescribing.
  • To assess the effectiveness of clinical decision rules within a pharmacist-led review service.
  • To quantify the reduction in potentially inappropriate prescriptions (PIPs) related to AMS.

Main Methods:

  • An interrupted time series study design was employed at University Hospitals Leuven.
  • An AMS-focused CMA, incorporating 41 clinical rules, was implemented post-standard-of-care.
  • A regression model analyzed the change in AMS-related residual PIPs before and after CMA implementation.

Main Results:

  • The median proportion of daily residual PIPs decreased from 75% to 8% post-CMA implementation.
  • The CMA intervention achieved an 86.70% relative reduction in AMS-related residual PIPs (P < 0.0001).
  • Over two years, 2790 recommendations were made with an 81.32% acceptance rate.

Conclusions:

  • The CMA approach significantly and sustainably reduced AMS-related residual PIPs.
  • Pharmacist-led clinical rule-based reviews are effective for improving antimicrobial prescribing.
  • The CMA service has potential for expansion to address other AMS objectives.

Related Concept Videos

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
485
Dosage Interval and Administration Route: Determination Methods01:19

Dosage Interval and Administration Route: Determination Methods

A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to...
28
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
21
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
5.1K
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
30
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.2K